Equitable access to inflammatory bowel disease care: challenges, strategies, and future directions

• by Johan Burisch, Rupa Banerjee, Gillian Watermeyer

• February 10, 2026

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study

• by Bregje Mol, Kim van Munster, Rinse Weersma, Akin Inderson, Kirsten Boonstra, Joost Drenth, Suzanne van Meer, Elsemieke de Vries, Marcel Spanier, Anton Vrij, Tessa Verlaan, Femke van Duijn, Willemijn Ponsioen, Marcel Dijkgraaf, Cyriel Ponsioen

• June 15, 2026

Holistic care in inflammatory bowel disease: is it in REACH?

• by Hyder Said, Calum D Moulton, Ailsa Hart, Laurie Keefer

• January 27, 2026

3 Innovations Revolutionizing IBD Treatment

Keck Medicine of USC gastroenterologist Florence-Damilola (Damie) Odufalu, MD, shares how recent advances in inflammatory bowel disease treatment are changing the lives of patients.

• by

• May 26, 2026

• 5 min